MannKind Corporation (MNKD) Outlines Expansion Plans and Revenue Targets

MannKind Corporation (NASDAQ:MNKD) is among the best NASDAQ penny stocks to bargain according to analysts. On 26 February, MannKind Corporation (NASDAQ:MNKD) shared its plans astatine the Oppenheimer healthcare conference. The institution said it expects beardown maturation from its main products. These see Afrezza for children, the FUROSCIX autoinjector, and a caller cause program, MNKD-201, for lung illness (IPF). Even though determination whitethorn beryllium contention from United Therapeutics, MannKind’s leaders said they consciousness affirmative astir the future.

The institution hopes to transcend $450 cardinal successful gross by 2026. It expects maturation from Afrezza, FUROSCIX, and royalties from Tyvaso DPI. The institution besides believes it could person $700 cardinal to $1 cardinal successful currency from Tyvaso implicit the adjacent fewer years.

Copyright: dolgachov / 123RF Stock Photo

Afrezza whitethorn soon beryllium approved for children, with a determination expected connected May 29. The institution is besides investigating a smaller dose to marque it easier for kids to use. FUROSCIX is expected to grow, particularly successful hospitals, and the caller autoinjector could assistance sales. MNKD-201 is present successful aboriginal studies, and much results are expected aboriginal this year.

On the aforesaid day, MannKind Corporation reported Q4 2025 revenues of $112 million, up 46% from the anterior year, with Furoscix and Afrezza each contributing $23 cardinal successful sales. Full-year 2025 gross reached $349 million, a 22% increase, boosted by the acquisition of scPharmaceuticals.

MannKind Corporation (NASDAQ:MNKD) is simply a biopharmaceutical institution focused connected improving attraction for chronic diseases.,It develops and sells treatments for superior wellness needs specified arsenic diabetes, pulmonary hypertension, and bosom failure. The institution besides works connected therapies for fluid overload successful chronic kidney disease.

While we admit the imaginable of MNKD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 11 Best Italian Stocks to Buy successful 2026.

Disclosure: None. Follow Insider Monkey connected Google News.